Sure, and when they can't compete on clinical data, they just cut their prices. They'll sucker punch customers who have switched once their current contract(s)/price offerings expire.
No wait just one minute! They are very smart, targeted, and educated. They are the best in the business. Oh , I know this, I asked them and they told me as much! Please do not change IPSEN.
Although the diseases the products treat are damn nasty, the SE profile is so bad, I really don't think patients will tolerate them. Hard to grow when people only take a few weeks of meds.
